Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $50.0000 (-16.67%) ($35.0000 - $55.0000) on Wed. Jun. 27, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.08% (three month average) | RSI | 31 | Latest Price | $50.0000(-16.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -7.8% a day on average for past five trading days. | Weekly Trend | CAPR declines -21% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XOP(3%) | Factors Impacting CAPR price | CAPR will decline at least -4.54% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) EWY(-1%) XLU(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.54% (StdDev 9.08%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $32.97(-34.06%) | Resistance Level | $81.83 | 5 Day Moving Average | $59.1(-15.4%) | 10 Day Moving Average | $68.34(-26.84%) | 20 Day Moving Average | $81.83(-38.9%) | To recent high | -80% | To recent low | 0% | Market Cap | $985m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |